EFFECTS OF JOSAMYCIN ON CARBAMAZEPINE KINETICS

被引:19
作者
VINCON, G
ALBIN, H
DEMOTESMAINARD, F
GUYOT, M
BISTUE, C
LOISEAU, P
机构
[1] HOP PELLEGRIN, CTR PHARMACOL CLIN, DEPT CLIN PHARMACOL, F-33076 BORDEAUX, FRANCE
[2] HOP PELLEGRIN, DEPT NEUROL, F-33076 BORDEAUX, FRANCE
关键词
D O I
10.1007/BF00607583
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The steady state pharmacokinetics of oral carbamazepine in epileptic patients (n = 8) was compared before and after one week of treatment with josamycin (2 g/day). There was a small but statistically significant decrease in oral clearance of total (17%) and unbound (21.5%) drug. In spite of an unchanged AUC of 10,11-epoxide carbamazepine the ratio of metabolite to parent drug AUC was significantly decreased (20.2%). The plasma protein binding of carbamazepine and its 10,11-epoxide metabolite did not vary. The results demonstrate impairment by josamycin of the apparent clearance of carbamazepine. Care should be taken in patient receiving both carbamazepine and josamycin.
引用
收藏
页码:321 / 323
页数:3
相关论文
共 20 条
[1]  
ALBIN H, 1982, THERAPIE, V37, P151
[2]  
[Anonymous], 2010, CLIN PHARMACOKINET
[3]  
BIGORIE B, 1975, NOUV PRESSE MED, V4, P2723
[4]  
BRAZIER JL, 1980, THERAPIE, V35, P545
[5]  
DRAVET C, 1977, NOUV PRESSE MED, V6, P467
[6]   CARBAMAZEPINE METABOLISM IN MAN INDUCTION AND PHARMACOGENETIC ASPECTS [J].
EICHELBAUM, M ;
TOMSON, T ;
TYBRING, G ;
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1985, 10 (01) :80-90
[7]   DETERMINATION OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE IN PLASMA BY HIGH-SPEED LIQUID-CHROMATOGRAPHY [J].
EICHELBAUM, M ;
BERTILSSON, L .
JOURNAL OF CHROMATOGRAPHY, 1975, 103 (01) :135-140
[8]  
FAIGLE JW, 1982, ANTIEPILEPTIC DRUGS
[9]  
Hayton A C, 1969, N Z Med J, V69, P42
[10]  
HOOPER WD, 1975, CLIN PHARMACOL THER, V17, P433